Skip to Content

CREON 1224 (Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease)

Generic Name: pancrelipase

Pill with imprint CREON 1224 is Orange / Clear, Capsule-shape and has been identified as Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease. It is supplied by Solvay Pharmaceuticals Inc..

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for CREON 1224

Creon 120,000 units amylase / 24,000 units lipase /  76,000 units protease CREON 1224
Creon 120,000 units amylase / 24,000 units lipase /  76,000 units protease CREON 1224
Creon 120,000 units amylase / 24,000 units lipase /  76,000 units protease CREON 1224

Creon

Generic Name
pancrelipase
Imprint
CREON 1224
Strength
120,000 units amylase / 24,000 units lipase / 76,000 units protease
Color
Orange / Clear
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Solvay Pharmaceuticals Inc.
National Drug Code (NDC)
00032-1224
Inactive Ingredients
cetyl alcohol, dimethicone, triethyl citrate, ferric oxide red, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, hypromellose phthalate (31% phthalate, 40 cst)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.